Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 7, 2011, Pages 514-521

  Baris, S ^a   Ercan, H ^b   Hasret Cagan, H ^a   Ozen, A ^b   Karakoc Aydiner, E ^a   Ozdemir, C ^a   Bahceciler, N N ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Children; Common variable immunodeficiency; Intravenous immunoglobulin

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; BRONCHIECTASIS; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; DELAYED DIAGNOSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LENGTH OF STAY; MALE; PRESCHOOL CHILD; PROGNOSIS; RESPIRATORY TRACT INFECTION; SCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; LENGTH OF STAY; MALE; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES;

EID: 83755225425     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodefi ciency) and ESID (European Society for Immunodefi ciencies). Clin Immunol. 1999;93:190-7.
2. Yong PF, Tarzi M, Chua I, Grimbacher B, Chee R. Common variable immunodeficiency: an update on etiology and management. Immunol Allergy Clin North Am. 2008;28:367-86.
3. Aydogan M, Eifan AO, Gocmen I, Ozdemir C, Bahceciler NN, Barlan IB. Clinical and immunologic features of pediatric patients with common variable immunodefi ciency and respiratory complications. J Investig Allergol Clin Immunol. 2008;18:260-5.
4. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2002;109:1001-4.
5. de Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ, de la Rosa D, Mata F, Andreu J, Morell F. Immunoglobulin therapy to control lung damage in patients with common variable immunodefi ciency. Int Immunopharmacol. 2004;4:745-53.
6. Eijkhout HW, van Der Meer JW, Kallenberg CG, Weening RS, van Dissel JT, Sanders LA, Strengers PF, Nienhuis H, Schellekens PT. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med. 2001;135:165-74.
7. Favre O, Leimgruber A, Nicole A, Spertini F. Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency. Allergy. 2005;60:385-90.
8. Tezcan I, Berkel AI, Ersoy F, Sanal O. Saǧli{dotless}kli{dotless} Türk çocuklari{dotless} ve erişkinlerde turbidometrik yöntemle baki{dotless}lan serum immunoglobulin düzeyleri. Çocuk Saǧli{dotless}ǧi{dotless} ve Hastali{dotless}klari{dotless} Dergisi. 1996;39:649-56.
9. Martínez G, De Rojas HF, Manzuri N, Spertini F. Respiratory disorders in common variable immunodefi ciency. Respir Med. 2001;95:191-5.
10. Sweinberg SK, Wodell RA, Grodofsky MP, Greene JM, Conley ME. Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia. J Allergy Clin Immunol. 1991;88:96-104.
11. Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, Debré P, Schmitt C, Oksenhendler E. Common variable immunodefi ciency patient classifi cation based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23:385-400.
12. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Noncystic-fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration. 2005;72:233-8.
13. Pirofsky B. Intravenous immune globulin therapy in hypogammaglobulinaemia. A Review. Am J Med. 1984;76:53-60.
14. Pruzanski W, Sussman G, Dorian W, Van T, Ibañez D, Redelmeier D. Relationship of dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodefi ciency. Infl ammation. 1996;20:353-9.
15. Roifman CM, Lederman HM, Lavi S, Stein LD, Levison H, Gelfand EW. Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med. 1985;79:171-4.
16. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP Jr, Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham- Rundles C. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117(4 Suppl):S525-53.
17. Yong PL, Boyle J, Ballow M, Boyle M, Berger M, Bleesing J, Bonilla FA, Chinen J, Cunninghamm-Rundles C, Fuleihan R, Nelson L, Wasserman RL, Williams KC, Orange JS. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology. Clin Immunol. 2010;135:255-63.
18. Garrod R, Lasserson T. Role of physiotherapy in the management of chronic lung diseases: an overview of systematic reviews. Respir Med. 2007;101:2429-36.
19. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34-48.
20. Atarod L, Raissi A, Aghamohammadi A, Farhoudi A, Khodadad A, Moin M, Pourpak Z, Movahedi M, Charagozlou M, Rezaei N. A review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during a 10-year period (1990-2000), in Children Hospital Medical Center. Iran J Allergy Asthma Immunol. 2003;2:75-9.
21. Khodadad A, Aghamohammadi A, Parvaneh N, Rezaei N, Mahjoob F, Bashashati M, Movahedi M, Fazlollahi MR, Zandieh F, Roohi Z, Abdollahzade S, Salavati A, Kouhi A, Talebpour B, Daryani NE. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci. 2007;52:2977-83.
22. Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody defi ciency syndromes. J Allergy Clin Immunol. 2009;124:658-64.
23. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, Claudio P, Franco D, Maria Pesce A, Borghese F, Guerra A, Rondelli R, Plebani A. Long term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308-16.
24. Luzi G, Zullo A, Iebba F, Rinaldi V, Sanchez Mete L, Muscaritoli M, Aiuti F. Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastroenterol. 2003;98:118-21.
25. Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, Hyde C, Chapel H. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149:410-23.
26. Bastlein C, Burlefinger R, Holzberg E, Voeth C, Garbrecht M, Ottenjann R. Common variable immunodeficiency syndrome and nodular lymphoid hyperplasia in the small intestine. Endoscopy. 1988;20:272-5.
27. Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, Viallard JF, Gardembas M, Galicier L, Schleinitz N, Suarez F, Soulas-Sprauel P, Hachulla E, Jaccard A, Gardeur A, Théodorou I, Rabian C, Debré P. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46:1547-54.
28. Skull S, Kemp A. Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-93. Arch Dis Child. 1996;74:527-30.